PaxMedica, Inc. Common Stock
PXMD · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,915 | $1,787 | $2,225 | $937 |
| G&A Expenses | $12,230,292 | $8,817 | $4,973 | $4,629 |
| SG&A Expenses | $12,230 | $8,817 | $4,973 | $4,629 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $16,145 | $10,604 | $7,198 | $5,566 |
| Operating Income | -$16,145 | -$10,604 | -$7,198 | -$5,566 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2,144 | -$4,197 | -$3,031 | -$2,260 |
| Pre-Tax Income | -$18,290 | -$14,802 | -$10,229 | -$7,826 |
| Tax Expense | $0 | $4,192 | $2,806 | $663 |
| Net Income | -$18,290 | -$14,802 | -$13,035 | -$8,489 |
| % Margin | – | – | – | – |
| EPS | -11 | -28.73 | -18.81 | -13.42 |
| % Growth | 61.7% | -52.7% | -40.2% | – |
| EPS Diluted | -11 | -28.73 | -18.81 | -13.42 |
| Weighted Avg Shares Out | 1,663 | 514 | 693 | 589 |
| Weighted Avg Shares Out Dil | 1,663 | 514 | 693 | 589 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $9 | $5 | $2,806 | $609 |
| Depreciation & Amortization | $2,135 | $0 | $173 | $0 |
| EBITDA | -$16,145 | -$16,508 | -$7,198 | -$5,619 |
| % Margin | – | – | – | – |